4.7 Article

Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor

期刊

CELL DEATH & DISEASE
卷 12, 期 7, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41419-021-03994-0

关键词

-

资金

  1. Vlaams Instituut voor Biotechnologie (VIB)
  2. Ghent University (iBOF ATLANTIS)
  3. Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [G035320N, G044518N, EOS MODEL-IDI 30826052, G.0E04.16N, G.0C76.18N, G.0B71.18N, G.0B96.20N, 1S02017N, 12T9118N]
  4. Flemish Government [BOF09/01M00709, BOF16/MET_V/007]
  5. EOS MODEL-IDI (FWO) [30826052]
  6. iBOF ATLANTIS [BOF20/IBF/039]
  7. Foundation against Cancer [F/2016/865, F/2020/1505]
  8. CRIG
  9. GIGG consortia
  10. National Institutes of Health, Department of Health, and Human Services [AI124049, AI144400]
  11. VIB

向作者/读者索取更多资源

The study reveals that BHA functions as a direct inhibitor of RIPK1 enzymatic activity, protecting cells from necroptosis and apoptosis. This finding suggests new functions of RIPK1 beyond its previously known roles.
Butylate hydroxyanisole (BHA) is a synthetic phenol that is widely utilized as a preservative by the food and cosmetic industries. The antioxidant properties of BHA are also frequently used by scientists to claim the implication of reactive oxygen species (ROS) in various cellular processes, including cell death. We report on the surprising finding that BHA functions as a direct inhibitor of RIPK1, a major signaling hub downstream of several immune receptors. Our in silico analysis predicts binding of 3-BHA, but not 2-BHA, to RIPK1 in an inactive DLG-out/Glu-out conformation, similar to the binding of the type III inhibitor Nec-1s to RIPK1. This predicted superior inhibitory capacity of 3-BHA over 2-BHA was confirmed in cells and using in vitro kinase assays. We demonstrate that the reported protective effect of BHA against tumor necrosis factor (TNF)-induced necroptotic death does not originate from ROS scavenging but instead from direct RIPK1 enzymatic inhibition, a finding that most probably extends to other reported effects of BHA. Accordingly, we show that BHA not only protects cells against RIPK1-mediated necroptosis but also against RIPK1 kinase-dependent apoptosis. We found that BHA treatment completely inhibits basal and induced RIPK1 enzymatic activity in cells, monitored at the level of TNFR1 complex I under apoptotic conditions or in the cytosol under necroptosis. Finally, we show that oral administration of BHA protects mice from RIPK1 kinase-dependent lethality caused by TNF injection, a model of systemic inflammatory response syndrome. In conclusion, our results demonstrate that BHA can no longer be used as a strict antioxidant and that new functions of RIPK1 may emerge from previously reported effects of BHA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据